Machine Learning Model for Transcriptomic Profiles from Omics Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current spatial transcriptomics technologies have limitations in providing a detailed understanding of complex tissues, such as the central nervous system, as they often rely on generalized large morphological features, failing to capture the underlying molecular consequences of patterns over large spatial areas effectively.

Innovation Solution

A computer-implemented method and system that utilizes machine learning to generate gene expression profiles from omics imaging data, including histology and spatial omics data, by processing images with a deployed machine learning model to produce transcriptomic profiles, enabling high-resolution spatial analysis and cell typing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If spatial transcriptomics uses large morphological features (100 μm features), then the device complexity is reduced and ease of operation is improved, but the measurement precision and ability to capture molecular consequences at cellular resolution deteriorates

Engineering Contradiction:
Improvespatial resolutionVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the tissue analysis into multiple hierarchical levels: first analyzing large morphological features at 100 μm scale, then progressively subdividing into smaller regions to achieve cellular resolution (2 μm scale). This segmentation allows the system to manage complexity by breaking down the large-scale analysis into manageable smaller units while maintaining high measurement precision at the finest scale.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a spatial dimension hierarchy by operating at multiple scales (100 μm to 2 μm). This dimensional approach allows the system to simultaneously capture both large-scale tissue architecture and fine-scale cellular molecular profiles, resolving the contradiction between ease of operation at large scales and measurement precision at small scales.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Area of stationary object

If spatial transcriptomics focuses on large spatial areas, then the area of analysis is increased and productivity is improved, but the measurement precision of molecular patterns at cellular level deteriorates

Engineering Contradiction:
Improvespatial coverageVSAvoidmolecular pattern resolution
Core Design Contradiction:
Area of stationary objectVSMeasurement precision

Solution Approach 1:

The patent divides the large spatial area into hierarchical segments: first processing broad tissue regions, then subdividing into smaller sub-regions for detailed molecular analysis. This segmentation enables the system to maintain high spatial coverage while achieving cellular-level molecular pattern resolution in each segment through progressive refinement.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies partial action by focusing high-resolution molecular analysis only on specific sub-regions of interest within the larger tissue area. Rather than applying maximum resolution uniformly across the entire tissue section, the system selectively intensifies analysis in key areas, maintaining overall productivity while achieving high measurement precision where needed.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20220180975A1Methods and systems for determining gene expression profiles and cell identities from multi-omic imaging data
Publication Date: 2022.06.09 THE BROAD INST INC
  • US20220180975A1 patent drawing
  • US20220180975A1 patent drawing
  • US20220180975A1 patent drawing

AI summary

The present disclosure relates to systems and method of determining transcriptomic profile from omics imaging data. The systems and methods train machine learning methods with intrinsic and extrinsic features of a cell and/or tissue to define transcriptomic profiles of the cell and/or tissue. Applicants utilize a convolutional autoencoder to define cell subtypes from images of the cells.